ProMIS Neurosciences, Inc.
PMN
$14.37
$1.8414.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 28.69M | 27.92M | 27.92M | 22.87M | 15.64M |
| Gross Profit | -28.69M | -27.92M | -27.92M | -22.87M | -15.64M |
| SG&A Expenses | 7.78M | 6.47M | 6.79M | 7.06M | 6.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.43M | 41.35M | 40.17M | 35.40M | 28.08M |
| Operating Income | -43.43M | -41.35M | -40.17M | -35.40M | -28.08M |
| Income Before Tax | -42.23M | -40.62M | -39.72M | -29.28M | -8.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.23 | -40.62 | -39.72 | -29.28 | -8.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.23M | -40.62M | -39.72M | -29.28M | -8.43M |
| EBIT | -43.43M | -41.35M | -40.17M | -35.40M | -28.08M |
| EBITDA | -- | -- | -- | -6.00M | -10.43M |
| EPS Basic | -12.61 | -18.59 | -22.60 | -18.63 | -4.98 |
| Normalized Basic EPS | -7.88 | -11.62 | -14.12 | -10.07 | -1.54 |
| EPS Diluted | -12.74 | -18.71 | -22.72 | -18.74 | -5.02 |
| Normalized Diluted EPS | -7.88 | -11.62 | -14.12 | -10.07 | -1.55 |
| Average Basic Shares Outstanding | 20.20M | 12.45M | 7.32M | 6.13M | 5.38M |
| Average Diluted Shares Outstanding | 20.20M | 12.45M | 7.32M | 6.13M | 5.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |